Ultrasound findings indicative of abnormal karyotype in fetuses with omphalocele
Study on the Efficacy of an Investigational Medication for Chronic Pain
Not Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Omphalocele
Age:
100 years or below
Gender: All
Who can participate: Participants aged 18 to 65 years with a diagnosis of chronic pain for at least six months are eligible. Key exclusion criteria include recent surgery and current use of other investigational drugs.
Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. They will be required to attend regular clinic visits for assessments and provide feedback on pain levels and quality of life.
Updated on
19 Feb 2024.
Study ID: 1011002881 (0704-75)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
